Cell Separation & Characterization in Solid Tumors: Global Markets Through 2023 - ResearchAndMarkets.com

The "Cell Separation and Characterization in Solid Tumors: Global Markets Through 2023" report has been added to ResearchAndMarkets.com's offering.

This report consists of the overall analysis of the market landscape.

It provides in-depth analysis on market size, growth opportunity in market and product types. The report will serve as a source for 360-degree analysis of the market, thoroughly integrating different models.

The report will help the companies and organizations have an all-around analysis of the cell separation and characterization in the solid tumor market and the most preferred markets regionally.

The report includes:

• An overview of the global markets and technologies for cell separation and characterization in solid tumors
• Analyses of global market trends with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023
• Overview of the main markers used for isolation, identification and purification for solid tumors, including surface cell-adhesion molecules such as CD133, CD24, hyaluronic acid (HA) receptor CD44, cytoprotective enzymes such as aldehyde dehydrogenase, ALDH, and transcription factors OCT-4, SOX-2
• Discussion of the various cell separation technique and technologies such as fluorescence-activated cell sorting (FACS), magnet-activated cell sorting (MACS), density gradient centrifugation, dielectrophoretic (DEP), aqueous two-phase system, field flow fractionation (FFF) and microfluidic platforms
• Coverage of the major products of the industry such as solid tumor kits, multi-marker solid tumor panels, reagents and microchips and micro-beads
• Comprehensive analysis of the major companies active in the market, including Abbvie, Inc., AstraZeneca, Beckman Coulter, Daiichi Sankyo and Pfizer, Inc.

Companies Profiled

• AAT Bioquest
• AbbVie, Inc.
• Abcodia Ltd.
• AstraZeneca
• Astrazeneca
• Beckman Coulter
• Bio-Techne Corp.
• Cayman Chemical
• Cell Biolabs, Inc.
• Daiichi Sankyo
• Eisai Co. Ltd.
• Epizyme, Inc.
• Genmab A/S
• Gilead Sciences, Inc.
• Glaxosmithkline Plc
• Illumina, Inc.
• Janssen
• Lidds
• Merck
• Miltenyi Biotech
• MP Biomedicals
• Neogenomics
• Novocure
• NSJ Bioreagents
• Onconova Therapeutics
• Perkinelmer, Inc.
• Pfizer Corp.
• Propanc Biopharma, Inc.
• R&D Activities
• Recent Activities
• Regnix
• Taiho Pharma
• Tesaro, Inc.
• Thermo Fisher Scientific
• and more...
  

For more information about this report visit https://www.researchandmarkets.com/research/6fjwhz/cell_separation?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181217005724/en/